Judit Rubio

ORCID: 0000-0001-9867-7535
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Lymphoma Diagnosis and Treatment
  • Inflammatory Biomarkers in Disease Prognosis
  • COVID-19 and healthcare impacts
  • Viral-associated cancers and disorders
  • Lung Cancer Treatments and Mutations
  • RNA modifications and cancer
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis B Virus Studies
  • Lung Cancer Diagnosis and Treatment
  • Neutropenia and Cancer Infections
  • Cancer, Lipids, and Metabolism
  • Immunodeficiency and Autoimmune Disorders
  • Bladder and Urothelial Cancer Treatments
  • Neonatal Health and Biochemistry
  • Wnt/β-catenin signaling in development and cancer
  • Immunotherapy and Immune Responses
  • Sarcoma Diagnosis and Treatment
  • Multiple and Secondary Primary Cancers
  • Congenital Anomalies and Fetal Surgery
  • Prostate Cancer Treatment and Research
  • COVID-19 Clinical Research Studies
  • Cervical Cancer and HPV Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Cancer Diagnosis and Treatment

Computer Vision Center
2025

Hospital Universitario de Móstoles
2019-2023

Madrid Institute for Advanced Studies
2020

Hospital Universitario Infanta Sofía
2009-2019

Hospital Universitario Puerta de Hierro Majadahonda
2013-2015

Cristian Pérez‐Granados Jon Morant Etxebarría Kevin Félix Arno Darras Oscar Humberto Marín Gómez Ivanova Claribel Orejuela Mendoza and 88 more Miguel Ángel Mohedano-Muñoz Erika Santamaría Giulia Bastianelli Alba Márquez-Rodríguez Michał Budka Gérard Bota Judit Rubio Eladio L. García de la Morena Manu Santa-Cruz Porfirio Nava Mario Fernández‐Tizón Hugo Sánchez-Mateos Adrián Barrero Juan Traba Tomasz S. Osiejuk Patrick J. Hart A Navine Alejandro González-Muñoz Carlos Barros de Araújo Gabriel Lima Medina Rosa Ingrid Maria Denóbile Torres Ana Luiza Camargo Catalano Cássio Rachid Simões Diego Llusia Morales Manuel M.B Pablo Acebes José M. Medina N.M.D. Brown Christos Astaras Ilias Karmiris Estanislao Aguayo Navarrete Maxime Cauchoix Luc Barbaro David Funosas Dominik Arend Sandra Müller Fernando González-García Alberto González-Romero Christos Mammides Michaelangelo Pontikis Giordano Jacuzzi Julian D. Olden Sara Bombaci Gabriel Marcacci Alain Jacot Juan Pablo Zurano Elena Gangenova Diego� Varela Facundo G. Di Sallo Gustavo A. Zurita Andrey Atemasov Junior A. Tremblay Vincent Lamarre Anja Hutschenreiter Alan Monroy-Ojeda Mauricio Díaz-Vallejo Sergio Chaparro‐Herrera Robert A. Briers Renata S. Sousa‐Lima Thiago Pinheiro Walmir da Silva Alice Calvente Anamaria Dal Molin Alexandre Antonelli Svetlana S. Gogoleva Igor V. Palko Hiếu Vũ Trọng Marina Henriques Lage Duarte Natália dos Santos Falcão Saturnino Stephanie Ribeiro Silva Ana Rainho Paula C. Lopes Karl‐Ludwig Schuchmann M Marques Ana Oliveira Nick A Littlewood Mao‐Ning Tuanmu Yi-Ru Cheng How‐Ran Chao Sebastian Kepfer‐Rojas A. Aguilera Bazán Lluı́s Brotons Mariano J. Feldman Louis Imbeau Pooja Panwar Aaron S. Weed Anant Dehwal Esther Sebastián‐González

<title>Abstract</title> Under the current global biodiversity crisis, there is a need for automated and non-invasive monitoring techniques that are able to gather large amounts of information cost-effectively at scales. One such technique passive acoustic monitoring, which commonly coupled with automatic identification animal species based on their sound. Automated sound analyses usually require training detection algorithms. These algorithms annotated datasets mark occurrence sounds...

10.21203/rs.3.rs-5729784/v1 preprint EN cc-by-nc Research Square (Research Square) 2025-01-04

Patients with lung cancer are at increased risk of SARS-CoV-2 infection and severe complications from COVID-19, but information on the efficacy anti-SARS-CoV-2 vaccine in these patients is scarce. We aimed evaluating safety immunogenicity COVID-19 vaccines this population.The prospective, nationwide SOLID substudy, enrolled adults who were fully vaccinated against COVID-19. Serum IgG antibody levels quantitatively assessed two weeks six months after receipt last dose using a chemiluminescent...

10.1016/j.lungcan.2023.107323 article EN cc-by-nc-nd Lung Cancer 2023-08-09

Hepatitis infection has a high prevalence in patients with non-Hodgkin lymphoma. Our objective was to evaluate clinical characteristics and survival of diagnosed diffuse large B-cell lymphoma (DLBCL) who were hepatitis B and/or C (HBV/HCV) positive. We reviewed 224 patents DLBCL found 21 be HBV/HCV positive (9.3%). Significant differences the number nodal regions affected, four versus two virus negative patients, liver involvement, which greater (28.6% vs. 10%, p = 0.028). No significant...

10.3109/10428194.2014.963576 article EN Leukemia & lymphoma/Leukemia and lymphoma 2014-09-15

e16109 Background: Prostate carcinoma (PC) achieves the healing in early stages with radiotherapy or radical prostatectomy. Despite this, there are patients advanced stages, either at time of diagnosis after a recurrence. The androgen deprivation is base disease treatment, being possibility that tumor evolves to an refractory phenotype, mainly due cell mutations hormonal receptor alterations, as well coexistence neuroendocrine component among adenocarcinoma cells. In present study, we...

10.1200/jco.2014.32.15_suppl.e16109 article EN Journal of Clinical Oncology 2014-05-20

This study was conducted to investigate the prognostic effect and implications of gallium 67 scintigraphy (gallium scan) at mid-treatment end first-line treatment in patients with early- advanced-stage Hodgkin's lymphoma (HL). A total 216 HL were included study. Gallium scan performed treatment. The overall survival (OS) event-free (EFS) calculated using Kaplan-Meier method. log-rank test used identify univariate predictors EFS OS. For early-stage disease, bulky mediastinal involvement (yes...

10.3892/mco.2015.670 article EN Molecular and Clinical Oncology 2015-11-09

Background: Although vaccination of patients with lung cancer against COVID-19 is supported by the major international societies worldwide, information on efficacy anti‑SARS‑CoV‑2 vaccines in this population limited. We therefore aimed to evaluate safety and immunogenicity COVID‑19 vaccines, durability immune response fully vaccinated patients.Methods: This was a substudy prospective, nationwide, longitudinal, multicenter SOLID study (Seroprevalence immunological memory SARS-CoV-2 patients),...

10.2139/ssrn.3978650 article EN SSRN Electronic Journal 2021-01-01

e19526 Background: The aim of the study was to evaluate clinical characteristics and survival patients diagnosed with diffuse large-B-cell lymphoma (DLBCL) positive hepatitis B and/or C virus (HBV-C). Methods: We reviewed 224 DLBCL in our hospital between October 1982 September 2013. Clinical, treatment following items were obtained. Results: found 21 HBV HCV (9.3%) [4 them (1.78%) both positive], 203 (90.7%) negative (NV), without significant differences respect age, gender, histological...

10.1200/jco.2014.32.15_suppl.e19526 article EN Journal of Clinical Oncology 2014-05-20

e15617 Background: Residual masses (RM) after treatment with orchiectomy and chemotherapy in patients germ cell tumors (GCT) may be positive for tumoral cells, necrosis or teratoma might implicated the prognosis of disease. Methods: We analyzed retrospectively 161 male diagnosed GCT treated between 1974 2012 our hospital a median follow up 8.1 years. compared evolution RM those without. Results: 159 had testicular 2 extragonadal tumors.41.5% were seminomas 59.5% non seminomatous.16% at stage...

10.1200/jco.2014.32.15_suppl.e15617 article EN Journal of Clinical Oncology 2014-05-20

e19520 Background: Many patients with Hodgkin´s Lymphoma (HL) are cured but they have an increased risk of developing second neoplasms (SN). We analyzed and compared their long-term thoracic malignancies (TM), (lung cancer or mesothelioma) to other neoplasms. Methods: retrospectively from January 1968 December 2012 a total 514 HL treated monitored in our hospital. reviewed as variables: date, age initial staging at diagnosis, type treatment (chemo, radiotherapy combined), presence bulky...

10.1200/jco.2014.32.15_suppl.e19520 article EN Journal of Clinical Oncology 2014-05-20

e19532 Background: The aim of this study was to evaluate the characteristics patients older and younger than 70 years diagnosed with follicular lymphoma (FL). Methods: A review clinical database 131 LF treated in our hospital between May 1980 January 2013 performed. Clinical, treatment, following items were obtained. Results: 34 age or (70.6 83.9 years) 98 (23-69.3 years), without significant differences respect gender, histology grade, stage Performance Status. extranodal involvement sites...

10.1200/jco.2013.31.15_suppl.e19532 article EN Journal of Clinical Oncology 2013-05-20

Congenital intrahepatic portosystemic shunts (IPSS) are abnormal vascular communications within the liver between branches of portal vein and hepatic veins. We present a case congenital IPSS in which there was intrauterine growth restriction. A 22-year-old woman, gravida 1, para 0, seen during routine antenatal scan at 30 + 1 weeks' gestation. The fetal size below 3rd percentile amniotic fluid volume biophysical profile were normal. Transverse abdomen demonstrated absence typical...

10.1002/uog.8774 article EN Ultrasound in Obstetrics and Gynecology 2010-10-01

Non-Hodgkin's lymphoma constitutes 40% of malignant lymphomas. Involvement the ovarian, either primarily or secondarily, appears to be very rare. A 38-year-old woman, presented with increasing weakness and mild lower abdominal pelvic pain 3 months duration. Transabdominal transvaginal ultrasound revealed large homogeneously solid lesions sharp borders in both ovarian. Color Doppler showed masses vascularised richly, exhibiting a color score 4. Subsequent computerized tomography (CT) imaging...

10.1002/uog.7303 article EN Ultrasound in Obstetrics and Gynecology 2009-09-01
Coming Soon ...